Superior Results for Myeloma Drug That's Added Earlier in Treatment

MONDAY, June 6, 2016 — A recently approved immunotherapy drug for a blood cancer called multiple myeloma can provide even better benefits if patients receive it earlier in their treatment, new clinical trial results show.
Darzalex (daratumumab)…
Source: Topamax